Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
acorda therapeutics
ampyra
apokyn
apomorphine
boston blog main
boston top stories
clinical trials
dalfampridine
duopa
inbrija
life sciences
mylan
national blog main
national top stories
new york
new york blog main
new york top stories
parkinson's disease
paul matteis
stiel
sunovion pharmaceuticals
What
drug
2
×
late
2
×
medications
2
×
new
acorda
amgen
approved
called
class
companies
conducted
cope
crippling
days
disease
episodes
erenumab
extra
fda
fewer
friday
gets
headaches
help
led
looms
lot
means
meant
migraine.the
migraines
month
nod
novartis
parkinson’s
patients
people
pharmaceutical
prevent
promises
Language
Current search:
late
×
medications
×
drug
×
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@theverge.com
7 years ago
This new drug promises fewer days a month with migraines
